Product details for DR5 Mouse (Murine) antibody
DR5 Mouse (Murine) antibody
Overview
| Antigen: | DR5 |
| Antibody Type: | Monoclonal |
| Application: | Flow Cytometry (FACS) |
| Reactivity: | Mouse (Murine) |
| Host: | Hamster |
| Quantity: | |
| Price: | 118,28 $ (Plus shipping costs and VAT, Invoice in EUR) |
| Order number: | ABIN157008 |
| Availability: | Ships within 7 to 10 days |
Additional Information: DR5 Mouse (Murine) antibody
| Antigen | DR5 |
| Immunogen | Mouse DR5-Ig fusion protein |
| Reactivity | Mouse (Murine) |
| Antibody Type | Monoclonal |
| Format | Purified |
| Isotype | Armenian Hamster IgG »Matching secondary antibodies |
| Description | CD262 is a 55 kD protein also known as DR5, TRAIL-R2, Apo-2, TRICK2, and KILLER. DR5 is member 10B of the TNF receptor superfamily (TNFRSF10B), widely expressed in normal tissues and some tumor cell lines. The DR5 receptor binds to TRAIL and interacts with the cytoplasmic proteins TRADD and RIP. TRAIL binding to DR5 activates NF- kappaB and induces apoptosis. DR5 is induced by wild-type p53. The MD5 antibody is useful for flow cytometry and activation of DR5 to induce cell killing in vitro and in vivo. Distribution: Widely expressed in normal tissues and some tumor cell lines. Expression regulated by the tumor suppressor p53 Function: Binds to TRAIL, activates NF- kappaB, induces apoptosis. May be involved in the regulation of tumor metastases. Synonyms: DR5, TRAIL-R2, TNFRS10B, TRICK2, KILLER Structure: Type I transmembrane protein, TNF receptor superfamily member, homotrimer, predicted molecular weight 55 kD |
| Clone | MD5-1 |
| Host | Hamster |
Application Details: DR5 Mouse (Murine) antibody
| Application | Flow Cytometry (FACS) |
| Application Notes | Additional reported applications (for the relevant formats) include: in vitro and in vivo induction of cytotoxicity. The LEAF(TM) purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm sterile-filtered) is recommended for functional assays (ABIN157015). Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is < 0.5 µg per 10 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance in each application. |
| Purification | The antibody was purified by affinity chromatography. |
| Buffer | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Storage | The antibody solution should be stored undiluted at 4 °C. |
| Research Area | Signaling, Apoptosis/Necrosis |
| Restrictions | For Research Use only |
Publications: DR5 Mouse (Murine) antibody
| Publications |
Sheridan, Marsters, Pitti et al.: "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors." In: Science (New York, N.Y.) , Vol. 277, Issue 5327, pp. 818-21, 1997/01 (PubMed) Wu, Burns, Zhan et al.: "Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor." In: Cancer research , Vol. 59, Issue 12, pp. 2770-5, 1999/01 (PubMed) Hayakawa, Screpanti, Yagita et al.: "NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy." In: Journal of immunology (Baltimore, Md. : 1950) , Vol. 172, Issue 1, pp. 123-9, 2003/01 (PubMed) Sato, Nakaoka, Yamashita et al.: "TRAIL-transduced dendritic cells protect mice from acute graft-versus-host disease and leukemia relapse." In: Journal of immunology (Baltimore, Md. : 1950) , Vol. 174, Issue 7, pp. 4025-33, 2005/01 (PubMed) Takeda, Yamaguchi, Akiba et al.: "Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy." In: The Journal of experimental medicine , Vol. 199, Issue 4, pp. 437-48, 2004/01 (PubMed) |
Product variants
External Information: DR5 Mouse (Murine) antibody
| Google Scholar | Find more references for clone MD5-1 on Google Scholar™ |
| EMBL Harvester | Search human, mouse or rat genome for antigen DR5 (Bioinformatic Harvester (EMBL)) |







